Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
Research has examined GHK-Cu's interactions with collagen synthesis pathways, metalloproteinase systems, and growth factor expression including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
The infusion is most effective when combined with diligent broad-spectrum SPF, sleep, hydration and where appropriate regenerative skin treatments such as skin boosters, polynucleotide therapy and energy-based collagen stimulation
The receptor will process the message by initiating other signaling events or cellular mechanisms that result in the target cells response